PolyNovo Keeps Bull After FY Revenue Beat -- Market Talk0124 GMT - PolyNovo keeps its bull at Macquarie after the skin-healing tech developerbeat fiscal 2024 revenue expectations. The investment bank's analysts tell clients in anote that the Australia-listed company's A$104.8 million annual revenue was about 1%stronger than they had anticipated, and about 2% higher than the average analystforecast. They think that fiscal 2024 will turn out to be PolyNovo's first profitableyear, and are looking for an underlying net profit of A$3.7 million. Looking furtherahead, they maintain their forecast of 48% fiscal 2025 sales growth and see recentlylaunched regions including India to grow as a proportion of total sales. Macquarie keepsa A$2.75 target price on the stock, which is up 2.5% at A$2.665.
Ann: FY24 Trading Result (unaudited), page-125
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.46 |
Change
-0.030(1.20%) |
Mkt cap ! $1.699B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.38 | $5.046M | 2.064M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12469 | $2.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |